Warenkorb

0.00
HPLC-getestetCOA jede ChargeEU-VersandSEPA · sichere ZahlungNur für Forschungszwecke
PEPTIQA BIOTECHSelank10 mgPurity 98.5% · RUO

Excellent

Ocena 4.8 / 5 — zgodnja ocena kakovosti

Peptiqa Reviews

Zgodnja ocena kakovosti — po prvem verified nakupu lahko kupci objavijo mnenje.

Selank

10 mg98.5% purityLot #SELANK-2026-001

Art.-Nr. der gewählten Abmessung: PEP-SELANK-10MG

Selank is a laboratory-developed heptapeptide with anxiolytic properties, originally created at the Institute of Molecular Genetics of the Russian Academy of Sciences. Its structure is derived from tuftsin, a naturally occurring immunomodulatory peptide (threonyl-lysyl-prolyl-arginine), which was modified by adding a Gly-Pro fragment to improve stability and biological activity. Through its influence on both GABAergic and serotonergic signaling pathways, Selank produces pronounced anti-anxiety effects that have been shown to be comparable to benzodiazepines, yet without causing sedation, cognitive dulling, or dependency. In Russia, Selank has been approved as a prescription treatment for generalized anxiety disorder. Studies further indicate that it promotes BDNF (Brain-Derived Neurotrophic Factor) production, supports memory formation, and regulates IL-6 cytokine activity, contributing to both neurological and immune benefits.
€67.10inkl. MwSt.
auf Lager (40)

Mengenpreise

MengeStückpreisErsparnis
1 vial67.10
3 vials (−7%)62.22−7%
5 vials (−12%)58.56−13%
Nakup & zberi 55 točk!

Ocene in mnenja

Prijavite se in ocenite izdelek po prejetem naročilu. Anmelden

Analysezertifikat

Lab-verifiziert
COA vor dem Kauf ansehen — Transparenz garantiert
Forschungsprofil

Selankwissenschaftliches Profil

Inhalt dient Bildungs- und Forschungszwecken. Research Use Only.

  • Selank is a laboratory-developed heptapeptide with anxiolytic properties, originally created at the Institute of Molecular Genetics of the Russian Academy of Sciences. Its structure is derived from tuftsin, a naturally occurring immunomodulatory peptide (threonyl-lysyl-prolyl-arginine), which was modified by adding a Gly-Pro fragment to improve stability and biological activity. Through its influence on both GABAergic and serotonergic signaling pathways, Selank produces pronounced anti-anxiety effects that have been shown to be comparable to benzodiazepines, yet without causing sedation, cognitive dulling, or dependency. In Russia, Selank has been approved as a prescription treatment for generalized anxiety disorder. Studies further indicate that it promotes BDNF (Brain-Derived Neurotrophic Factor) production, supports memory formation, and regulates IL-6 cytokine activity, contributing to both neurological and immune benefits.

Mehr aus Nootropiki

Diese Seite verwendet Cookies

Accept